AAAAAA
Results: 1-25/26
Authors:
Seznec, H
Agbulut, O
Sergeant, N
Savouret, C
Ghestem, A
Tabti, N
Willer, JC
Ourth, L
Duros, C
Brisson, E
Fouquet, C
Butler-Browne, G
Delacourte, A
Junien, C
Gourdon, G
Citation: H. Seznec et al., Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities, HUM MOL GEN, 10(23), 2001, pp. 2717-2726
Authors:
Sergeant, N
Sablonniere, B
Schraen-Maschke, S
Ghestem, A
Maurage, CA
Wattez, A
Vermersch, P
Delacourte, A
Citation: N. Sergeant et al., Dysregulation of human brain microtubule-associated tau mRNA maturation inmyotonic dystrophy type 1, HUM MOL GEN, 10(19), 2001, pp. 2143-2155
Authors:
Maurage, CA
Sergeant, N
Ruchoux, MM
Hauw, JJ
Delacourte, A
Citation: Ca. Maurage et al., Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals, NEUROREPORT, 12(15), 2001, pp. 3177-3181
Authors:
Guise, S
Braguer, D
Carles, G
Delacourte, A
Briand, C
Citation: S. Guise et al., Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells, J NEUROSC R, 63(3), 2001, pp. 257-267
Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease
Authors:
Riederer, BM
Mourton-Gilles, C
Frey, P
Delacourte, A
Probst, A
Citation: Bm. Riederer et al., Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease, J NEUROCYT, 30(2), 2001, pp. 145-158
Authors:
Buee, L
Delacourte, A
Citation: L. Buee et A. Delacourte, Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?, NEUROBIOL A, 22(1), 2001, pp. 115-118
Authors:
Delacourte, A
Citation: A. Delacourte, Neurofibrillary degeneration: Patterns of tau isoform expression, ALZHEIMER'S DISEASE, 2001, pp. 587-599
Authors:
Ledesma, MD
Da Silva, JS
Crassaerts, K
Delacourte, A
De Strooper, B
Dotti, CG
Citation: Md. Ledesma et al., Brain plasmin enhances APP alpha-cleavage and A beta degradation and is reduced in Alzheimer's disease brains, EMBO REP, 1(6), 2000, pp. 530-535
Authors:
Mailliot, C
Podevin-Dimster, V
Rosenthal, RE
Sergeant, N
Delacourte, A
Fiskum, T
Buee, L
Citation: C. Mailliot et al., Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion, J CEREBR B, 20(3), 2000, pp. 543-549
Authors:
Buee, L
Bussiere, T
Buee-Scherrer, V
Delacourte, A
Hof, PR
Citation: L. Buee et al., Tau protein isoforms, phosphorylation and role in neurodegenerative disorders, BRAIN RES R, 33(1), 2000, pp. 95-130
Authors:
Delacourte, A
Citation: A. Delacourte, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease - Reply, NEUROLOGY, 54(2), 2000, pp. 538-538
Authors:
Ferreira, S
Dupire, MJ
Delacourte, A
Najib, J
Caillet-Boudin, ML
Citation: S. Ferreira et al., Synthesis and regulation of apolipoprotein E during the differentiation ofhuman neuronal precursor NT2/D1 cells into postmitotic neurons, EXP NEUROL, 166(2), 2000, pp. 415-421
Authors:
Ishizawa, K
Ksiezak-Reding, H
Davies, P
Delacourte, A
Tiseo, P
Yen, SH
Dickson, DW
Citation: K. Ishizawa et al., A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease, ACT NEUROP, 100(3), 2000, pp. 235-244
Authors:
Delacourte, A
Citation: A. Delacourte, Biochemical and molecular characterization of neurofibrillary degenerationin frontotemporal dementias, DEMENT G C, 10, 1999, pp. 75-79
Authors:
Buee, L
Delacourte, A
Citation: L. Buee et A. Delacourte, Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease, BRAIN PATH, 9(4), 1999, pp. 681-693
Authors:
Brique, S
Destee, A
Lambert, JC
Mouroux, V
Delacourte, A
Amouyel, P
Chartier-Harlin, MC
Citation: S. Brique et al., A new GTP-cyclohydrolase I mutation in an unusual dopa-responsive dystonia, familial form, NEUROREPORT, 10(3), 1999, pp. 487-491
Authors:
Soulie, C
Mitchell, V
Dupont-Wallois, L
Chartier-Harlin, MC
Beauvillain, JC
Delacourte, A
Caillet-Boudin, ML
Citation: C. Soulie et al., Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE, NEUROSCI L, 265(2), 1999, pp. 147-150
Authors:
Perez-Tur, J
Buee, L
Morris, HR
Waring, SC
Onstead, L
Wavrant-De Vrieze, F
Crook, R
Buee-Scherrer, V
Hof, PR
Petersen, RC
McGeer, PL
Delacourte, A
Hutton, M
Siddique, T
Ahlskog, JE
Hardy, J
Steele, JC
Citation: J. Perez-tur et al., Neurodegenerative diseases of Guam: Analysis of TAU, NEUROLOGY, 53(2), 1999, pp. 411-413
Authors:
Delacourte, A
David, JP
Sergeant, N
Buee, L
Wattez, A
Vermersch, P
Ghozali, F
Fallet-Bianco, C
Pasquier, F
Lebert, F
Petit, H
Di Menza, C
Citation: A. Delacourte et al., The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease, NEUROLOGY, 52(6), 1999, pp. 1158-1165
Authors:
Sato, N
Hori, O
Yamaguchi, A
Lambert, JC
Chartier-Harlin, MC
Robinson, PA
Delacourte, A
Schmidt, AM
Furuyama, T
Imaizumi, K
Tohyama, M
Takagi, T
Citation: N. Sato et al., A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue, J NEUROCHEM, 72(6), 1999, pp. 2498-2505
Authors:
Sergeant, N
Wattez, A
Delacourte, A
Citation: N. Sergeant et al., Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively "exon 10" isoforms, J NEUROCHEM, 72(3), 1999, pp. 1243-1249
Authors:
Bussiere, T
Hof, PR
Mailliot, C
Brown, CD
Caillet-Boudin, ML
Perl, DP
Buee, L
Delacourte, A
Citation: T. Bussiere et al., Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration, ACT NEUROP, 97(3), 1999, pp. 221-230
Authors:
Delacourte, A
Citation: A. Delacourte, Etiology of Alzheimer's disease, RESEARCH AND PRACTICE IN ALZHEIMER'S DISEASE, VOL 2, 1999, pp. 40-47
Authors:
Lambert, JC
Berr, C
Pasquier, F
Delacourte, A
Frigard, B
Cottel, D
Perez-Tur, J
Mouroux, V
Mohr, M
Cecyre, D
Galasko, D
Lendon, C
Poirier, J
Hardy, J
Mann, D
Amouyel, P
Chartier-Harlin, MC
Citation: Jc. Lambert et al., The risk of developing Alzheimer's disease associated with the APOE promoter polymorphisms, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 47-52
Authors:
Delacourte, A
Buee, L
David, JP
Sergeant, N
Wattez, A
Vermersch, P
Pasquier, F
Lebert, F
Ghozali, F
Fallet-Bianco, C
Di Menza, C
Citation: A. Delacourte et al., Lack of continuum between cerebral aging and Alzheimer's disease as revealed by PHF-tau and A beta biochemistry, ALZHEIM REP, 1(2), 1998, pp. 101-110